DeepMed Research

NATIONAL JEWISH HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1899-01-01

Employees: -

Market Cap: -

Website: http://www.nationaljewish.org/

Clinical Trials

Effect of Omalizumab in the Skin of Food Allergy Patients

Phase 4

Recruiting

Conditions: Food Allergy
Food Allergy in Children

Interventions: Drug: Omalizumab Injection

First Posted Date: 2024-10-01

Last Posted Date: 2025-05-02

Lead Sponsor: National Jewish Health

Target Recruit Count: 40

Registration Number: NCT06618963

Locations: 🇺🇸
National Jewish Health, Denver, Colorado, United States

Enhancing Hypnotic Medication Discontinuation in Primary Care

Phase 4

Recruiting

Conditions: Insomnia
Hypnotic Dependence

Interventions: Behavioral: Digital Cognitive Behavioral Therapy
Behavioral: Structured Medication Tapering

First Posted Date: 2024-05-30

Last Posted Date: 2025-02-24

Lead Sponsor: National Jewish Health

Target Recruit Count: 430

Registration Number: NCT06435520

Locations: 🇺🇸
National Jewish Health, Denver, Colorado, United States

Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma

Phase 1

Not yet recruiting

Conditions: Asthma; Eosinophilic
Asthma

Interventions: Drug: Lipopolysaccharides

First Posted Date: 2024-02-21

Last Posted Date: 2024-02-21

Lead Sponsor: National Jewish Health

Target Recruit Count: 60

Registration Number: NCT06270576

Locations: 🇺🇸
National Jewish Health, Denver, Colorado, United States

Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria

Conditions: Cystic Fibrosis
Nontuberculous Mycobacterium Infection
Mycobacterium Infections
Mycobacterium; Pulmonary
Nontuberculous Mycobacterial Lung Disease

Interventions: Biological: mycobacteriophage

First Posted Date: 2024-02-16

Last Posted Date: 2025-05-21

Lead Sponsor: National Jewish Health

Target Recruit Count: 10

Registration Number: NCT06262282

Locations: 🇺🇸
John Hopkins University, Baltimore, Maryland, United States
🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

and more 15 locations

Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)

Recruiting

Conditions: Nontuberculous Mycobacterial Pulmonary Infection
Mycobacterium Infections
Outbreak Investigation
Healthcare Associated Infection

Interventions: Other: Epidemiologic investigation

First Posted Date: 2023-12-04

Last Posted Date: 2023-12-12

Lead Sponsor: National Jewish Health

Target Recruit Count: 100

Registration Number: NCT06155747

Locations: 🇺🇸
National Jewish Health, Denver, Colorado, United States

Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor Via Reverse Phase High Performance liquiD chromatographY

Conditions: Cystic Fibrosis

First Posted Date: 2023-04-20

Last Posted Date: 2023-07-24

Lead Sponsor: National Jewish Health

Target Recruit Count: 100

Registration Number: NCT05822102

Locations: 🇺🇸
National Jewish Health, Denver, Colorado, United States
🇺🇸
St. Joseph Hospital, Denver, Colorado, United States

Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria

Conditions: Cystic Fibrosis
Nontuberculous Mycobacterial Pulmonary Infection

First Posted Date: 2023-01-17

Last Posted Date: 2023-05-08

Lead Sponsor: National Jewish Health

Target Recruit Count: 100

Registration Number: NCT05686837

Locations: 🇺🇸
National Jewish Health, Denver, Colorado, United States

COVID-19 Vaccine Response in Chronic Respiratory Conditions

Recruiting

Conditions: SARS-CoV Infection

Interventions: Biological: COVID-19 vaccine

First Posted Date: 2022-04-06

Last Posted Date: 2022-04-06

Lead Sponsor: National Jewish Health

Target Recruit Count: 600

Registration Number: NCT05313087

Locations: 🇺🇸
National Jewish Health, Denver, Colorado, United States

Reverse HFpEF: Ketogenic Reversal of Heart Failure With Preserved Ejection Fraction Study

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Other: Ketogenic Diet

First Posted Date: 2021-06-28

Last Posted Date: 2024-04-03

Lead Sponsor: National Jewish Health

Target Recruit Count: 16

Registration Number: NCT04942548

Locations: 🇺🇸
National Jewish Health and University of Colorado Denver, Denver, Colorado, United States
🇺🇸
Saint Joseph Hospital, Denver, Colorado, United States

A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis

Active, not recruiting

Conditions: Hypersensitivity Pneumonitis

First Posted Date: 2021-04-14

Last Posted Date: 2025-05-14

Lead Sponsor: National Jewish Health

Target Recruit Count: 137

Registration Number: NCT04844359

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy